Nurix Therapeutics, Inc. (NRIX) Earnings
|
Expand Research on NRIX
| Next EPS Date | 1/28/27 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -6.9% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +9.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/12/26 | Q326 | $4.73 | N/A | N/A | $673.1M | $7.9M | N/A | ![]() | ![]() | Details | |
| 10/9/26 |
Q326 | N/A | -$0.61 | N/A | N/A | $23.57M | N/A | N/A | N/A | ||
| 7/9/26 |
Q226 | N/A | -$0.72 | N/A | N/A | $15.92M | N/A | N/A | N/A | ||
| 4/8/26 |
Q126 | -$0.79 | -$0.76 | -$0.03 | $6.25M | $14.25M | N/A | ![]() | ![]() | Details | |
| 1/28/26 |
Q425 | -$0.82 | -$0.92 | +$0.10 | $13.6M | $14.28M | N/A | ![]() | ![]() | Details | |
| 10/9/25 | Q325 | -$1.03 | -$0.83 | -$0.20 | $7.89M | $16.05M | N/A | ![]() | ![]() | Details | |
| 7/10/25 |
Q225 | N/A | -$0.71 | N/A | N/A | $16.9M | N/A | N/A | N/A | ||
| 4/8/25 |
Q125 | N/A | -$0.76 | N/A | N/A | $13.55M | N/A | N/A | N/A |



